146 related articles for article (PubMed ID: 1686323)
1. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
Reyes G; Ramírez T; Hong E
Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
[No Abstract] [Full Text] [Related]
2. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
Vanĕcek M; Trcka V; Helfert I
Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
[No Abstract] [Full Text] [Related]
3. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation.
Da Re P; Valenti P; Fabbri G; Frigeni V; Reggiani A; Della Bella D
Drugs Exp Clin Res; 1988; 14(11):687-92. PubMed ID: 2907738
[TBL] [Abstract][Full Text] [Related]
4. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
Marchetti G; Di Francesco GF; Baldoli E
Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
[No Abstract] [Full Text] [Related]
5. [Studies on the action of talinolol (Cordanum, 02-115) on the coronary blood circulation].
Modersohn D; Femmer K
Pharmazie; 1975 Oct; 30(10):652-5. PubMed ID: 689
[No Abstract] [Full Text] [Related]
6. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)].
Ishihara T; Watanabe K; Takenaka F
Arzneimittelforschung; 1977; 27(11):2055-9. PubMed ID: 23789
[No Abstract] [Full Text] [Related]
7. [Beta-1 and beta-2 blocking activities of a new series of (arylalkoxy) propanolamines].
Rosell G; Mauleón D; Pujol MD; Granados R
Arch Farmacol Toxicol; 1986 Apr; 12(1):65-70. PubMed ID: 2874776
[No Abstract] [Full Text] [Related]
8. Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].
Boudot JP; Cavero I; Fénard S; Lefèvre-Borg F; Manoury P; Roach AG
Br J Pharmacol; 1979 Jul; 66(3):445P. PubMed ID: 43176
[No Abstract] [Full Text] [Related]
9. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
Haustein KO; Fiehring H; Oltmanns G; Femmer K
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
[No Abstract] [Full Text] [Related]
10. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
Noguchi Y; Nakao K; Kato H; Takagi K
Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
[No Abstract] [Full Text] [Related]
11. Puerarin beta-adrenergic receptor blocking effect.
Lu XR; Gao E; Xu LZ; Li HZ; Kang B; Chen WN; Chen SM; Chai XS
Chin Med J (Engl); 1987 Jan; 100(1):25-8. PubMed ID: 2885157
[No Abstract] [Full Text] [Related]
12. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
Lindner E
Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
Karppanen H; Lahovaara S; Mattila MJ
Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
[No Abstract] [Full Text] [Related]
14. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
[No Abstract] [Full Text] [Related]
15. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
Caputi AP; Marmo E; Saini RK
Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
[No Abstract] [Full Text] [Related]
16. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
Smith RD; Barrett JA; Wolf PS; Pruss TP
Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
[No Abstract] [Full Text] [Related]
17. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
19. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
Prahl P; Prahl M
Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
[No Abstract] [Full Text] [Related]
20. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
